nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C19—Prednisone—ankylosing spondylitis	0.114	0.171	CbGbCtD
Bicalutamide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0912	0.137	CbGbCtD
Bicalutamide—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0714	0.107	CbGbCtD
Bicalutamide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0691	0.104	CbGbCtD
Bicalutamide—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0593	0.0889	CbGbCtD
Bicalutamide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0593	0.0889	CbGbCtD
Bicalutamide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0585	0.0877	CbGbCtD
Bicalutamide—CYP3A4—Prednisone—ankylosing spondylitis	0.0553	0.0828	CbGbCtD
Bicalutamide—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0542	0.0813	CbGbCtD
Bicalutamide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0345	0.0517	CbGbCtD
Bicalutamide—Haemorrhage—Prednisone—ankylosing spondylitis	0.000631	0.0019	CcSEcCtD
Bicalutamide—Syncope—Triamcinolone—ankylosing spondylitis	0.000623	0.00187	CcSEcCtD
Bicalutamide—Syncope—Methylprednisolone—ankylosing spondylitis	0.000622	0.00187	CcSEcCtD
Bicalutamide—Oedema—Prednisolone—ankylosing spondylitis	0.000617	0.00185	CcSEcCtD
Bicalutamide—Neutropenia—Methotrexate—ankylosing spondylitis	0.000616	0.00185	CcSEcCtD
Bicalutamide—Dysuria—Methotrexate—ankylosing spondylitis	0.000616	0.00185	CcSEcCtD
Bicalutamide—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000611	0.00184	CcSEcCtD
Bicalutamide—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00061	0.00183	CcSEcCtD
Bicalutamide—Shock—Prednisolone—ankylosing spondylitis	0.000607	0.00182	CcSEcCtD
Bicalutamide—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000607	0.00182	CcSEcCtD
Bicalutamide—Cough—Triamcinolone—ankylosing spondylitis	0.000607	0.00182	CcSEcCtD
Bicalutamide—Hypertension—Triamcinolone—ankylosing spondylitis	0.0006	0.0018	CcSEcCtD
Bicalutamide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000599	0.0018	CcSEcCtD
Bicalutamide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000596	0.00179	CcSEcCtD
Bicalutamide—Myalgia—Triamcinolone—ankylosing spondylitis	0.000592	0.00178	CcSEcCtD
Bicalutamide—Pneumonia—Methotrexate—ankylosing spondylitis	0.000591	0.00177	CcSEcCtD
Bicalutamide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00059	0.00177	CcSEcCtD
Bicalutamide—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000588	0.00177	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000586	0.00176	CcSEcCtD
Bicalutamide—Depression—Methotrexate—ankylosing spondylitis	0.000586	0.00176	CcSEcCtD
Bicalutamide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000579	0.00174	CcSEcCtD
Bicalutamide—Angioedema—Dexamethasone—ankylosing spondylitis	0.000576	0.00173	CcSEcCtD
Bicalutamide—Angioedema—Betamethasone—ankylosing spondylitis	0.000576	0.00173	CcSEcCtD
Bicalutamide—Angiopathy—Prednisone—ankylosing spondylitis	0.000572	0.00172	CcSEcCtD
Bicalutamide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000571	0.00172	CcSEcCtD
Bicalutamide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000571	0.00171	CcSEcCtD
Bicalutamide—Immune system disorder—Prednisone—ankylosing spondylitis	0.00057	0.00171	CcSEcCtD
Bicalutamide—Oedema—Triamcinolone—ankylosing spondylitis	0.000567	0.0017	CcSEcCtD
Bicalutamide—Syncope—Dexamethasone—ankylosing spondylitis	0.000566	0.0017	CcSEcCtD
Bicalutamide—Syncope—Betamethasone—ankylosing spondylitis	0.000566	0.0017	CcSEcCtD
Bicalutamide—Arrhythmia—Prednisone—ankylosing spondylitis	0.000564	0.00169	CcSEcCtD
Bicalutamide—Infection—Triamcinolone—ankylosing spondylitis	0.000564	0.00169	CcSEcCtD
Bicalutamide—Sweating—Methotrexate—ankylosing spondylitis	0.000563	0.00169	CcSEcCtD
Bicalutamide—Infection—Methylprednisolone—ankylosing spondylitis	0.000562	0.00169	CcSEcCtD
Bicalutamide—Haematuria—Methotrexate—ankylosing spondylitis	0.00056	0.00168	CcSEcCtD
Bicalutamide—Shock—Triamcinolone—ankylosing spondylitis	0.000558	0.00168	CcSEcCtD
Bicalutamide—Insomnia—Prednisolone—ankylosing spondylitis	0.000558	0.00168	CcSEcCtD
Bicalutamide—Alopecia—Prednisone—ankylosing spondylitis	0.000558	0.00167	CcSEcCtD
Bicalutamide—Shock—Methylprednisolone—ankylosing spondylitis	0.000557	0.00167	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000556	0.00167	CcSEcCtD
Bicalutamide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000555	0.00167	CcSEcCtD
Bicalutamide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000554	0.00167	CcSEcCtD
Bicalutamide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000554	0.00167	CcSEcCtD
Bicalutamide—Epistaxis—Methotrexate—ankylosing spondylitis	0.000554	0.00166	CcSEcCtD
Bicalutamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000554	0.00166	CcSEcCtD
Bicalutamide—Mental disorder—Prednisone—ankylosing spondylitis	0.000553	0.00166	CcSEcCtD
Bicalutamide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00055	0.00165	CcSEcCtD
Bicalutamide—Malnutrition—Prednisone—ankylosing spondylitis	0.000549	0.00165	CcSEcCtD
Bicalutamide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000548	0.00165	CcSEcCtD
Bicalutamide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000547	0.00164	CcSEcCtD
Bicalutamide—Hypertension—Dexamethasone—ankylosing spondylitis	0.000545	0.00164	CcSEcCtD
Bicalutamide—Hypertension—Betamethasone—ankylosing spondylitis	0.000545	0.00164	CcSEcCtD
Bicalutamide—Myalgia—Dexamethasone—ankylosing spondylitis	0.000537	0.00161	CcSEcCtD
Bicalutamide—Myalgia—Betamethasone—ankylosing spondylitis	0.000537	0.00161	CcSEcCtD
Bicalutamide—Anxiety—Dexamethasone—ankylosing spondylitis	0.000535	0.00161	CcSEcCtD
Bicalutamide—Anxiety—Betamethasone—ankylosing spondylitis	0.000535	0.00161	CcSEcCtD
Bicalutamide—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00053	0.00159	CcSEcCtD
Bicalutamide—Pain—Prednisolone—ankylosing spondylitis	0.000528	0.00158	CcSEcCtD
Bicalutamide—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000527	0.00158	CcSEcCtD
Bicalutamide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000523	0.00157	CcSEcCtD
Bicalutamide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000521	0.00156	CcSEcCtD
Bicalutamide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000517	0.00155	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000517	0.00155	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000516	0.00155	CcSEcCtD
Bicalutamide—Oedema—Dexamethasone—ankylosing spondylitis	0.000515	0.00155	CcSEcCtD
Bicalutamide—Oedema—Betamethasone—ankylosing spondylitis	0.000515	0.00155	CcSEcCtD
Bicalutamide—Insomnia—Triamcinolone—ankylosing spondylitis	0.000513	0.00154	CcSEcCtD
Bicalutamide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000512	0.00154	CcSEcCtD
Bicalutamide—Infection—Betamethasone—ankylosing spondylitis	0.000511	0.00154	CcSEcCtD
Bicalutamide—Infection—Dexamethasone—ankylosing spondylitis	0.000511	0.00154	CcSEcCtD
Bicalutamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000509	0.00153	CcSEcCtD
Bicalutamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000508	0.00153	CcSEcCtD
Bicalutamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000508	0.00153	CcSEcCtD
Bicalutamide—Visual impairment—Methotrexate—ankylosing spondylitis	0.000508	0.00153	CcSEcCtD
Bicalutamide—Anaemia—Prednisone—ankylosing spondylitis	0.000508	0.00152	CcSEcCtD
Bicalutamide—Shock—Dexamethasone—ankylosing spondylitis	0.000506	0.00152	CcSEcCtD
Bicalutamide—Shock—Betamethasone—ankylosing spondylitis	0.000506	0.00152	CcSEcCtD
Bicalutamide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000506	0.00152	CcSEcCtD
Bicalutamide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000505	0.00152	CcSEcCtD
Bicalutamide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000505	0.00152	CcSEcCtD
Bicalutamide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000504	0.00151	CcSEcCtD
Bicalutamide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000504	0.00151	CcSEcCtD
Bicalutamide—Angioedema—Prednisone—ankylosing spondylitis	0.000502	0.00151	CcSEcCtD
Bicalutamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000499	0.0015	CcSEcCtD
Bicalutamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000498	0.0015	CcSEcCtD
Bicalutamide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000498	0.00149	CcSEcCtD
Bicalutamide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000498	0.00149	CcSEcCtD
Bicalutamide—Syncope—Prednisone—ankylosing spondylitis	0.000493	0.00148	CcSEcCtD
Bicalutamide—Anorexia—Betamethasone—ankylosing spondylitis	0.000491	0.00147	CcSEcCtD
Bicalutamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000491	0.00147	CcSEcCtD
Bicalutamide—Urticaria—Prednisolone—ankylosing spondylitis	0.00049	0.00147	CcSEcCtD
Bicalutamide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000489	0.00147	CcSEcCtD
Bicalutamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.000489	0.00147	CcSEcCtD
Bicalutamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000488	0.00147	CcSEcCtD
Bicalutamide—Pain—Triamcinolone—ankylosing spondylitis	0.000485	0.00146	CcSEcCtD
Bicalutamide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000483	0.00145	CcSEcCtD
Bicalutamide—Angiopathy—Methotrexate—ankylosing spondylitis	0.000478	0.00144	CcSEcCtD
Bicalutamide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000476	0.00143	CcSEcCtD
Bicalutamide—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000475	0.00143	CcSEcCtD
Bicalutamide—Hypertension—Prednisone—ankylosing spondylitis	0.000474	0.00142	CcSEcCtD
Bicalutamide—Chills—Methotrexate—ankylosing spondylitis	0.000473	0.00142	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000469	0.00141	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000469	0.00141	CcSEcCtD
Bicalutamide—Myalgia—Prednisone—ankylosing spondylitis	0.000468	0.0014	CcSEcCtD
Bicalutamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000467	0.0014	CcSEcCtD
Bicalutamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000466	0.0014	CcSEcCtD
Bicalutamide—Anxiety—Prednisone—ankylosing spondylitis	0.000466	0.0014	CcSEcCtD
Bicalutamide—Alopecia—Methotrexate—ankylosing spondylitis	0.000466	0.0014	CcSEcCtD
Bicalutamide—Insomnia—Betamethasone—ankylosing spondylitis	0.000466	0.0014	CcSEcCtD
Bicalutamide—Insomnia—Dexamethasone—ankylosing spondylitis	0.000466	0.0014	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000464	0.00139	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000463	0.00139	CcSEcCtD
Bicalutamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000462	0.00139	CcSEcCtD
Bicalutamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000462	0.00139	CcSEcCtD
Bicalutamide—Mental disorder—Methotrexate—ankylosing spondylitis	0.000462	0.00139	CcSEcCtD
Bicalutamide—Malnutrition—Methotrexate—ankylosing spondylitis	0.000459	0.00138	CcSEcCtD
Bicalutamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000454	0.00137	CcSEcCtD
Bicalutamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000453	0.00136	CcSEcCtD
Bicalutamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000453	0.00136	CcSEcCtD
Bicalutamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000451	0.00135	CcSEcCtD
Bicalutamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00045	0.00135	CcSEcCtD
Bicalutamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000448	0.00135	CcSEcCtD
Bicalutamide—Oedema—Prednisone—ankylosing spondylitis	0.000448	0.00135	CcSEcCtD
Bicalutamide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000447	0.00134	CcSEcCtD
Bicalutamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000447	0.00134	CcSEcCtD
Bicalutamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000447	0.00134	CcSEcCtD
Bicalutamide—Infection—Prednisone—ankylosing spondylitis	0.000445	0.00134	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000444	0.00133	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000444	0.00133	CcSEcCtD
Bicalutamide—Back pain—Methotrexate—ankylosing spondylitis	0.000444	0.00133	CcSEcCtD
Bicalutamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.000444	0.00133	CcSEcCtD
Bicalutamide—Fatigue—Betamethasone—ankylosing spondylitis	0.000444	0.00133	CcSEcCtD
Bicalutamide—Shock—Prednisone—ankylosing spondylitis	0.000441	0.00132	CcSEcCtD
Bicalutamide—Pain—Dexamethasone—ankylosing spondylitis	0.00044	0.00132	CcSEcCtD
Bicalutamide—Pain—Betamethasone—ankylosing spondylitis	0.00044	0.00132	CcSEcCtD
Bicalutamide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00044	0.00132	CcSEcCtD
Bicalutamide—Skin disorder—Prednisone—ankylosing spondylitis	0.000435	0.00131	CcSEcCtD
Bicalutamide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000433	0.0013	CcSEcCtD
Bicalutamide—Anorexia—Prednisone—ankylosing spondylitis	0.000427	0.00128	CcSEcCtD
Bicalutamide—Anaemia—Methotrexate—ankylosing spondylitis	0.000424	0.00127	CcSEcCtD
Bicalutamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000424	0.00127	CcSEcCtD
Bicalutamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000424	0.00127	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000421	0.00126	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000421	0.00126	CcSEcCtD
Bicalutamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000418	0.00126	CcSEcCtD
Bicalutamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000417	0.00125	CcSEcCtD
Bicalutamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000409	0.00123	CcSEcCtD
Bicalutamide—Urticaria—Betamethasone—ankylosing spondylitis	0.000409	0.00123	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000408	0.00123	CcSEcCtD
Bicalutamide—Dizziness—Prednisolone—ankylosing spondylitis	0.000408	0.00123	CcSEcCtD
Bicalutamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000407	0.00122	CcSEcCtD
Bicalutamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000407	0.00122	CcSEcCtD
Bicalutamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000407	0.00122	CcSEcCtD
Bicalutamide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000407	0.00122	CcSEcCtD
Bicalutamide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000407	0.00122	CcSEcCtD
Bicalutamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000406	0.00122	CcSEcCtD
Bicalutamide—Insomnia—Prednisone—ankylosing spondylitis	0.000405	0.00122	CcSEcCtD
Bicalutamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000403	0.00121	CcSEcCtD
Bicalutamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000401	0.00121	CcSEcCtD
Bicalutamide—Cough—Methotrexate—ankylosing spondylitis	0.000401	0.0012	CcSEcCtD
Bicalutamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.0004	0.0012	CcSEcCtD
Bicalutamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.000395	0.00119	CcSEcCtD
Bicalutamide—Chest pain—Methotrexate—ankylosing spondylitis	0.000391	0.00117	CcSEcCtD
Bicalutamide—Myalgia—Methotrexate—ankylosing spondylitis	0.000391	0.00117	CcSEcCtD
Bicalutamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00039	0.00117	CcSEcCtD
Bicalutamide—Rash—Prednisolone—ankylosing spondylitis	0.000389	0.00117	CcSEcCtD
Bicalutamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000389	0.00117	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000388	0.00117	CcSEcCtD
Bicalutamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000387	0.00116	CcSEcCtD
Bicalutamide—Fatigue—Prednisone—ankylosing spondylitis	0.000386	0.00116	CcSEcCtD
Bicalutamide—Headache—Prednisolone—ankylosing spondylitis	0.000386	0.00116	CcSEcCtD
Bicalutamide—Constipation—Prednisone—ankylosing spondylitis	0.000383	0.00115	CcSEcCtD
Bicalutamide—Confusional state—Methotrexate—ankylosing spondylitis	0.000378	0.00113	CcSEcCtD
Bicalutamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000375	0.00113	CcSEcCtD
Bicalutamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000374	0.00112	CcSEcCtD
Bicalutamide—Infection—Methotrexate—ankylosing spondylitis	0.000372	0.00112	CcSEcCtD
Bicalutamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000369	0.00111	CcSEcCtD
Bicalutamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000369	0.00111	CcSEcCtD
Bicalutamide—Asthenia—Betamethasone—ankylosing spondylitis	0.000369	0.00111	CcSEcCtD
Bicalutamide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000367	0.0011	CcSEcCtD
Bicalutamide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000367	0.0011	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000367	0.0011	CcSEcCtD
Bicalutamide—Nausea—Prednisolone—ankylosing spondylitis	0.000366	0.0011	CcSEcCtD
Bicalutamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000364	0.00109	CcSEcCtD
Bicalutamide—Pruritus—Betamethasone—ankylosing spondylitis	0.000364	0.00109	CcSEcCtD
Bicalutamide—Skin disorder—Methotrexate—ankylosing spondylitis	0.000364	0.00109	CcSEcCtD
Bicalutamide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000362	0.00109	CcSEcCtD
Bicalutamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000361	0.00108	CcSEcCtD
Bicalutamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00036	0.00108	CcSEcCtD
Bicalutamide—Rash—Triamcinolone—ankylosing spondylitis	0.000358	0.00107	CcSEcCtD
Bicalutamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000357	0.00107	CcSEcCtD
Bicalutamide—Anorexia—Methotrexate—ankylosing spondylitis	0.000357	0.00107	CcSEcCtD
Bicalutamide—Rash—Methylprednisolone—ankylosing spondylitis	0.000357	0.00107	CcSEcCtD
Bicalutamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000357	0.00107	CcSEcCtD
Bicalutamide—Urticaria—Prednisone—ankylosing spondylitis	0.000356	0.00107	CcSEcCtD
Bicalutamide—Headache—Triamcinolone—ankylosing spondylitis	0.000355	0.00107	CcSEcCtD
Bicalutamide—Headache—Methylprednisolone—ankylosing spondylitis	0.000355	0.00107	CcSEcCtD
Bicalutamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000354	0.00106	CcSEcCtD
Bicalutamide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000354	0.00106	CcSEcCtD
Bicalutamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000352	0.00106	CcSEcCtD
Bicalutamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000352	0.00106	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000341	0.00103	CcSEcCtD
Bicalutamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00034	0.00102	CcSEcCtD
Bicalutamide—Dizziness—Betamethasone—ankylosing spondylitis	0.00034	0.00102	CcSEcCtD
Bicalutamide—Insomnia—Methotrexate—ankylosing spondylitis	0.000339	0.00102	CcSEcCtD
Bicalutamide—Nausea—Triamcinolone—ankylosing spondylitis	0.000337	0.00101	CcSEcCtD
Bicalutamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000336	0.00101	CcSEcCtD
Bicalutamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000336	0.00101	CcSEcCtD
Bicalutamide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000334	0.001	CcSEcCtD
Bicalutamide—Somnolence—Methotrexate—ankylosing spondylitis	0.000333	0.001	CcSEcCtD
Bicalutamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00033	0.000992	CcSEcCtD
Bicalutamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00033	0.000991	CcSEcCtD
Bicalutamide—Vomiting—Betamethasone—ankylosing spondylitis	0.000327	0.000983	CcSEcCtD
Bicalutamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000327	0.000983	CcSEcCtD
Bicalutamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000326	0.000978	CcSEcCtD
Bicalutamide—Rash—Dexamethasone—ankylosing spondylitis	0.000325	0.000975	CcSEcCtD
Bicalutamide—Rash—Betamethasone—ankylosing spondylitis	0.000325	0.000975	CcSEcCtD
Bicalutamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000324	0.000974	CcSEcCtD
Bicalutamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000324	0.000974	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000323	0.000972	CcSEcCtD
Bicalutamide—Fatigue—Methotrexate—ankylosing spondylitis	0.000323	0.00097	CcSEcCtD
Bicalutamide—Headache—Dexamethasone—ankylosing spondylitis	0.000322	0.000969	CcSEcCtD
Bicalutamide—Headache—Betamethasone—ankylosing spondylitis	0.000322	0.000969	CcSEcCtD
Bicalutamide—Asthenia—Prednisone—ankylosing spondylitis	0.000322	0.000966	CcSEcCtD
Bicalutamide—Pain—Methotrexate—ankylosing spondylitis	0.00032	0.000962	CcSEcCtD
Bicalutamide—Pruritus—Prednisone—ankylosing spondylitis	0.000317	0.000953	CcSEcCtD
Bicalutamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000309	0.000927	CcSEcCtD
Bicalutamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000307	0.000921	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000306	0.00092	CcSEcCtD
Bicalutamide—Nausea—Betamethasone—ankylosing spondylitis	0.000306	0.000918	CcSEcCtD
Bicalutamide—Nausea—Dexamethasone—ankylosing spondylitis	0.000306	0.000918	CcSEcCtD
Bicalutamide—Urticaria—Methotrexate—ankylosing spondylitis	0.000298	0.000894	CcSEcCtD
Bicalutamide—Dizziness—Prednisone—ankylosing spondylitis	0.000296	0.00089	CcSEcCtD
Bicalutamide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000296	0.00089	CcSEcCtD
Bicalutamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000296	0.00089	CcSEcCtD
Bicalutamide—Vomiting—Prednisone—ankylosing spondylitis	0.000285	0.000856	CcSEcCtD
Bicalutamide—Rash—Prednisone—ankylosing spondylitis	0.000283	0.000849	CcSEcCtD
Bicalutamide—Dermatitis—Prednisone—ankylosing spondylitis	0.000282	0.000848	CcSEcCtD
Bicalutamide—Headache—Prednisone—ankylosing spondylitis	0.000281	0.000844	CcSEcCtD
Bicalutamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000276	0.000829	CcSEcCtD
Bicalutamide—Asthenia—Methotrexate—ankylosing spondylitis	0.000269	0.000807	CcSEcCtD
Bicalutamide—Nausea—Prednisone—ankylosing spondylitis	0.000266	0.0008	CcSEcCtD
Bicalutamide—Pruritus—Methotrexate—ankylosing spondylitis	0.000265	0.000796	CcSEcCtD
Bicalutamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000256	0.00077	CcSEcCtD
Bicalutamide—Dizziness—Methotrexate—ankylosing spondylitis	0.000248	0.000744	CcSEcCtD
Bicalutamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000238	0.000715	CcSEcCtD
Bicalutamide—Rash—Methotrexate—ankylosing spondylitis	0.000236	0.00071	CcSEcCtD
Bicalutamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000236	0.000709	CcSEcCtD
Bicalutamide—Headache—Methotrexate—ankylosing spondylitis	0.000235	0.000705	CcSEcCtD
Bicalutamide—Nausea—Methotrexate—ankylosing spondylitis	0.000223	0.000668	CcSEcCtD
